Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 EFSA Approves Vitamin K2-MK7 as Novel Food - Nutraceuticals World

What are you searching for?

Sign in
Regulations

EFSA Approves Vitamin K2-MK7 as Novel Food

By: Lisa Olivo

, Rodman Media

Norway-based CLS Technology AS and Vesta Ingredients, Inc., Indianapolis, IN, have announced that Vesta’s Vitamin K2-MK7 is now approved and recognized by EFSA as a novel food in the E.U. In addition, CLS Technology has been given the exclusive right to distribute it in Europe.
 
Morten Sundstoe, founder and CEO of CLS Technology, commented, “As one of the founders of NattoPharma, I introduced K2 in the market in 2009. The market for vitamin K2 is still a niche market, because both the quality and price has not been good enough. After years of product development, Vesta has been able to make, what I would say, is the best quality natural K2 at a competitive price.”
 
He added,  “We are very pleased to be VESTA’s representative in Europe, and we see a great potential for our K2 products in Europe now that it is recognized as novel food.”

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics